WEGOVY INJECTION 1.7 MG (SEMAGLUTIDE)

उत्पाद वर्णन

Wegovy (semaglutide) 1.7 mg is a prescription, once-weekly injectable medication used as part of a medically supervised treatment plan for chronic weight management in adults with obesity or those who are overweight with at least one weight-related health condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol).

This 1.7 mg dose is part of the Wegovy titration schedule. It follows the 1 mg dose and prepares the body to transition to the full maintenance dose of 2.4 mg. Wegovy works by mimicking GLP-1, a naturally occurring hormone that regulates appetite and calorie intake, helping patients feel fuller and reduce food cravings.

Wegovy should be used in combination with a reduced-calorie diet and increased physical activity for optimal results.

---

FAQs about Wegovy 1.7 mg Injection

1. What is Wegovy 1.7 mg used for?

Wegovy 1.7 mg is a step in the dosage escalation process. It helps your body continue adjusting to semaglutide with the goal of minimizing side effects as you approach the full therapeutic dose of 2.4 mg weekly.

2. When do I take the 1.7 mg dose?

You typically take Wegovy 1.7 mg for weeks 13ï16 in the dosing schedule:

• Weeks 1ï4: 0.25 mg

• Weeks 5ï8: 0.5 mg

• Weeks 9ï12: 1 mg

• Weeks 13ï16: 1.7 mg

• Week 17 onward: 2.4 mg (maintenance)

Your healthcare provider may adjust this schedule depending on how you tolerate each dose.

3. How is Wegovy 1.7 mg administered?

• Inject once weekly, on the same day each week.

• Can be taken at any time of day, with or without food.

• Administer subcutaneously into the abdomen, thigh, or upper arm.

• Rotate injection sites to avoid skin irritation.

4. What are common side effects at 1.7 mg?

Side effects are typically similar to lower doses and may include:

• Nausea

• Vomiting

• Diarrhea or constipation

• Abdominal discomfort

• Fatigue or dizziness

• Injection site reactions

These are generally temporary and decrease as your body adjusts. Contact your healthcare provider if symptoms become severe or persistent.

5. What if I miss a dose?

If you miss a dose:

• Take it as soon as you remember within 5 days of the missed injection.

• If more than 5 days have passed, skip the missed dose and continue with your next scheduled injection.

• Do not double up to make up for a missed dose.

6. Can I stay on 1.7 mg long-term?

While 1.7 mg is an important step in titration, it is not typically the maintenance dose. Most patients move on to 2.4 mg for maximum therapeutic effect. However, some may remain at 1.7 mg if they are unable to tolerate the higher doseïthis decision should be made with your healthcare provider.

7. Who should not take Wegovy?

Wegovy is not recommended for individuals who:

• Have a personal or family history of medullary thyroid cancer (MTC) or MEN2

• Are pregnant or planning to become pregnant

• Are breastfeeding

• Have had a serious allergic reaction to semaglutide or any of its ingredients

8. How effective is Wegovy overall?

In clinical studies, patients on Wegovy (up to 2.4 mg) lost an average of 15% of their body weight over 68 weeks when combined with a healthy diet and physical activity. The 1.7 mg dose is a key step in reaching this level of treatment efficacy.

Clinically Proven Weight Loss Support

WEGOVY Injection contains 1.7 mg of Semaglutide, a medication recognized for its role in effective, medically supervised weight management in adults. It acts by mimicking natural hormones that regulate appetite and food intake, supporting sustainable fat reduction. Sourced from reputable suppliers in India, it offers an advanced option for those committed to clinically guided weight control.


Safe Handling and Storage

To preserve its potency, WEGOVY Injection should be stored below 30C and kept away from direct sunlight. Proper storage ensures medication stability and effectiveness. It is delivered in secure packaging to maintain its quality during transport and storage, suitable for both individual patients and medical professionals.